Aslan Fred · Chief Executive Officer at Artiva Biotherapeutics, Inc. · 27d agono track record yet
Sold 61,696 @ $6.84 avg · $421,828 · 2026-10-05
Form 4: Aslan Fred sold ARTV
Aslan Fred (Chief Executive Officer at Artiva Biotherapeutics, Inc.) reported an open-market sale of 61,696 shares of ARTV at an average $6.84, roughly $421,828, in a Form 4 filed 2026-10-06.
At post $7.27Now $4.19-42.4% since postedas of Nov 2, 4:15 PM ET
1d-3.7%
3d-4.5%
1w-13.5%
1m—
3m—
6m—
1y—